Status:
UNKNOWN
Matrix Metalloproteinases in Atherosclerosis of Chronic Kidney Disease
Lead Sponsor:
Aristotle University Of Thessaloniki
Collaborating Sponsors:
AHEPA University Hospital
Conditions:
Diabetic Nephropathy
Eligibility:
All Genders
50-75 years
Brief Summary
The purpose of this study is to determine whether matrix metalloproteinases are associated with atherosclerosis in the different stages of chronic kidney disease.
Detailed Description
The purpose of this study is to determine the correlation of matrix metalloproteinases and atherosclerosis of chronic kidney disease. Patients with diabetes mellitus type 2,as a non-inflammatory leadi...
Eligibility Criteria
Inclusion
- Chronic kidney disease
- Diabetes mellitus type 2
Exclusion
- Malignancy
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2016
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT01458158
Start Date
October 1 2011
End Date
May 1 2016
Last Update
February 23 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AHEPA University Hospital, Medical School of Aristotle University of Thessaloniki
Thessaloniki, Greece